Biotransformation of doxepin by Cunninghamella elegans

Drug Metabolism and Disposition

Volumn 27, Issue 10, 1999, Pages 1157-1164

  Moody, Joanna D ^a   Freeman, James P ^a   Cerniglia, Carl E ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXY N NORDOXEPIN; 2 HYDROXYDOXEPIN; DOXEPIN; DOXEPIN N OXIDE; DRUG DERIVATIVE; DRUG METABOLITE; GLUCURONIDE; NORDOXEPIN; UNCLASSIFIED DRUG;

ARTICLE; CUNNINGHAMELLA; DRUG STRUCTURE; DRUG TRANSFORMATION; ISOMERISM; MAMMAL; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STEREOCHEMISTRY;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CUNNINGHAMELLA; DOXEPIN; MASS SPECTROMETRY;

EID: 0032824448     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Budavari S, O'Neil MJ, Smith A, Heckelman PE and Kinneary JF (eds) (1997) The Merck Index, 12th ed., p 581, Merck & Co, Inc., Whitehouse Station, New Jersey.
2. Cerniglia CE (1997) Fungal metabolism of polycyclic aromatic hydrocarbons: Past, present, and future applications in bioremediation. J Ind Microbiol Biotechnol 19:324-333.
3. Deuschle M, Haertter S, Hiemke C, Standhardt H and Heuser I (1997) Doxepin and its metabolites in plasma and cerebrospinal fluid in depressed patients. Psychopharmacology 131:19-22.
4. Duhart BT Jr, Zhang D, Deck J, Freeman JP and Cerniglia CE (1999) Biotransformation of protriptyline by filamentous fungi and yeasts. Xenobiotica 29:733-746.
5. Godfrey RG (1996) A guide to the understanding and use of tricyclic antidepressants in the overall management of fibromyalgia and other chronic pain syndromes. Arch Intern Med 156:1047-1052.
6. Hobbs DC (1969) Distribution and metabolism of doxepin. Biochem Pharmacol 18:1941-1954.
7. Luo H, Hawes EM, McKay G, Korchinski ED and Midha KK (1991) The quarternary ammonium-linked glucuronide of doxepin: A major metabolite in depressed patients treated with doxepin. Drug Metab Dispos 19:722-724.
8. Physicians' Desk Reference (1997) 51st ed., pp 2028, Medical Economics Press, Montvale, New Jersey.
9. Pinder RM, Brogden RN, Speight TM and Avery GS (1977) Doxepin up-to-date: A review of its pharmacological properties and therapeutic efficacy with particular reference to depression. Drugs 13:161-218.
10. Rao GP and Davis PJ (1997) Microbial models of mammalian metabolism: Biotransformations of HP 749 (Besipiridine) using Cunninghamella elegans. Drug Metab Dispos 25:709-715.
11. Shu YZ, Hubbard JW, Cooper JK, McKay G, Korchinski ED, Kumar R and Midha KK (1990a) The identification of urinary metabolites of doxepin in patients. Drug Metab Dispos 18:735-741.
12. Shu YZ, Hubbard JW, McKay G and Midha KK (1990b) Identification of phenolic doxepin glucuronides from patient urine and rat bile. Drug Metab Dispos 18:1096-1099.
13. Smith PF and Corelli RL (1997) Doxepin in the management of pruritus associated with allergic cutaneous reactions. Ann Pharmacother 31:633-635.
14. Van J-H, Hubbard JW, McKay G and Midha KK (1997) Stereoselective in vivo and in vitro studies on the metabolism of doxepin and N-desmethyldoxepin. Xenobiotica 27:1245-1257.
15. Zhang D, Evans FE, Freeman JP, Duhart BT and Cerniglia CE (1995) Biotransformation of amitriptyline by Cunninghamella elegans. Drug Metab Dispos 23:1417-1425.
16. Zhang D, Evans FE, Freeman JP, Yang Y, Deck J and Cerniglia CE (1996) Formation of mammalian metabolites of cyclobenzaprine by the fungus, Cunninghamella elegans. Chem-Biol Interact 102:79-92.